A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: The ASSURE study

by Stryjewski M.E., Lentnek A., O'Riordan W., Pullman J., Tambyah P.A., Miró J.M., Fowler Jr. V.G., Barriere S.L., Kitt M.M., Corey G.R.
Published 2018